LynxsurfBio

LynxsurfBio (LSSB) is building an AI assisted proteomics analytics platform for enabling precision medicne and early diagnosis of dementia rooted in various forms of neurodegenerative diseases. Based on the unique biosensing technology specially designed for on-demand, multiplexed biomarkers quantification using only a few microlitres of blood, LSB's ambition is to provide physicians and clinicians real-time guidance on optimizing dementia treatment efficacy through predictive models of individualized neurobiomarker profiles.